Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maroua Manai

Showing results (1-10 of 24) with videos related to

Pageof 3
Sort By:
International Review of Cell and Molecular Biology|April 18, 2024
PrefaceMaroua Manai, Hamouda Boussen, Massimo Cristofanilli
Nanomaterials (Basel, Switzerland)|August 27, 2025
Green Synthesis of Chitosan-Coated Selenium Nanoparticles for Paclitaxel DeliveryMouhaned Y Al-Darwesh, Maroua Manai, Hammouda Chebbi, et al.
Cancers|January 21, 2023
Cell-of-Origin Targeted Drug Repurposing for Triple-Negative and Inflammatory Breast Carcinoma with HDAC and HSP90 Inhibitors Combined with NiclosamideUdayan Bhattacharya, Mohammad Kamran, Maroua Manai, et al.
Human Immunology|September 6, 2022
FOXP3+/CD68+ ratio within the tumor microenvironment may serve as a potential prognostic factor in classical Hodgkin lymphomaImen Zawati, Olfa Adouni, Maroua Manai, et al.
Annals of Diagnostic Pathology|May 6, 2022
Association of ZEB1 and Vimentin with poor prognosis in metaplastic breast cancerImen Zawati, Aida Jlassi, Olfa Adouni, et al.
Pathology|March 22, 2025
Can residual proliferative cancer burden predict long-term outcomes following neoadjuvant chemotherapy in breast cancer?Imen Zawati, Yousra Troujette, Olfa Adouni, et al.
International Review of Cell and Molecular Biology|April 18, 2024
Inflammatory breast cancer: Epidemiologic data and therapeutic resultsHamouda Boussen, Yosra Berrazaga, Sherif Kullab, et al.
Cancer Biomarkers : Section a of Disease Markers|November 28, 2019
MARCKS protein overexpression is associated with poor prognosis in male breast cancerMaroua Manai, Syrine Abdeljaoued, Aïda Goucha, et al.
In Vivo (Athens, Greece)|December 29, 2019
Overexpression of Annexin A1 Is an Independent Predictor of Longer Overall Survival in Epithelial Ovarian CancerMaroua Manai, Raoudha Doghri, Pascal Finetti, et al.
Frontiers in Oncology|April 18, 2024
VISTA/CTLA4/PD1 coexpression on tumor cells confers a favorable immune microenvironment and better prognosis in high-grade serous ovarian carcinomaAida Jlassi, Rim Rejaibi, Maroua Manai, et al.
Pageof 3

Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
International Review of Cell and Molecular Biology|April 18, 2024
PrefaceMaroua Manai, Hamouda Boussen, Massimo Cristofanilli
Nanomaterials (Basel, Switzerland)|August 27, 2025
Green Synthesis of Chitosan-Coated Selenium Nanoparticles for Paclitaxel DeliveryMouhaned Y Al-Darwesh, Maroua Manai, Hammouda Chebbi, et al.
Cancers|January 21, 2023
Cell-of-Origin Targeted Drug Repurposing for Triple-Negative and Inflammatory Breast Carcinoma with HDAC and HSP90 Inhibitors Combined with NiclosamideUdayan Bhattacharya, Mohammad Kamran, Maroua Manai, et al.
Human Immunology|September 6, 2022
FOXP3+/CD68+ ratio within the tumor microenvironment may serve as a potential prognostic factor in classical Hodgkin lymphomaImen Zawati, Olfa Adouni, Maroua Manai, et al.
Annals of Diagnostic Pathology|May 6, 2022
Association of ZEB1 and Vimentin with poor prognosis in metaplastic breast cancerImen Zawati, Aida Jlassi, Olfa Adouni, et al.
Pathology|March 22, 2025
Can residual proliferative cancer burden predict long-term outcomes following neoadjuvant chemotherapy in breast cancer?Imen Zawati, Yousra Troujette, Olfa Adouni, et al.
International Review of Cell and Molecular Biology|April 18, 2024
Inflammatory breast cancer: Epidemiologic data and therapeutic resultsHamouda Boussen, Yosra Berrazaga, Sherif Kullab, et al.
Cancer Biomarkers : Section a of Disease Markers|November 28, 2019
MARCKS protein overexpression is associated with poor prognosis in male breast cancerMaroua Manai, Syrine Abdeljaoued, Aïda Goucha, et al.
In Vivo (Athens, Greece)|December 29, 2019
Overexpression of Annexin A1 Is an Independent Predictor of Longer Overall Survival in Epithelial Ovarian CancerMaroua Manai, Raoudha Doghri, Pascal Finetti, et al.
Frontiers in Oncology|April 18, 2024
VISTA/CTLA4/PD1 coexpression on tumor cells confers a favorable immune microenvironment and better prognosis in high-grade serous ovarian carcinomaAida Jlassi, Rim Rejaibi, Maroua Manai, et al.
Pageof 3